Cargando…

Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme

Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will...

Descripción completa

Detalles Bibliográficos
Autores principales: Millett, Piers, Alexanian, Tessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996700/
https://www.ncbi.nlm.nih.gov/pubmed/36968257
http://dx.doi.org/10.1049/enb2.12012
_version_ 1784903101269934080
author Millett, Piers
Alexanian, Tessa
author_facet Millett, Piers
Alexanian, Tessa
author_sort Millett, Piers
collection PubMed
description Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will make this challenging. There will be a growing need for flexible risk management approaches, which can be rapidly adapted as technology and societal needs change. This study details efforts by the International Genetically Engineered Machine (iGEM) competition in creating and implementing an adaptive risk management approach. It concludes with key lessons and challenges: working with hazardous materials, such as dangerous pathogens, toxins and chemicals; managing risks to plants, animals and the environment; use of samples from people, animals, and the environment; improving the hazards identified; variations in risk perception and tolerance; variation in terminology that complicates interpretation of risk management plans; and connections with broader societal or ethical questions, such as animal use, gender and sexuality, or benefit sharing.
format Online
Article
Text
id pubmed-9996700
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99967002023-03-24 Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme Millett, Piers Alexanian, Tessa Eng Biol Case Study Synthetic biology offers exciting possibilities to deal with local and global challenges over the coming decades. As we make greater use of biological engineering, it will be increasingly important to balance potential risks and benefits. The rate, scale, and diffusion of relevant capabilities will make this challenging. There will be a growing need for flexible risk management approaches, which can be rapidly adapted as technology and societal needs change. This study details efforts by the International Genetically Engineered Machine (iGEM) competition in creating and implementing an adaptive risk management approach. It concludes with key lessons and challenges: working with hazardous materials, such as dangerous pathogens, toxins and chemicals; managing risks to plants, animals and the environment; use of samples from people, animals, and the environment; improving the hazards identified; variations in risk perception and tolerance; variation in terminology that complicates interpretation of risk management plans; and connections with broader societal or ethical questions, such as animal use, gender and sexuality, or benefit sharing. John Wiley and Sons Inc. 2021-09-01 /pmc/articles/PMC9996700/ /pubmed/36968257 http://dx.doi.org/10.1049/enb2.12012 Text en © 2021 The Authors. Engineering Biology published by John Wiley & Sons Ltd on behalf of The Institution of Engineering and Technology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Study
Millett, Piers
Alexanian, Tessa
Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title_full Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title_fullStr Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title_full_unstemmed Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title_short Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme
title_sort implementing adaptive risk management for synthetic biology: lessons from igem's safety and security programme
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996700/
https://www.ncbi.nlm.nih.gov/pubmed/36968257
http://dx.doi.org/10.1049/enb2.12012
work_keys_str_mv AT millettpiers implementingadaptiveriskmanagementforsyntheticbiologylessonsfromigemssafetyandsecurityprogramme
AT alexaniantessa implementingadaptiveriskmanagementforsyntheticbiologylessonsfromigemssafetyandsecurityprogramme